Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,083,130,660
New position
Shares Held
5,491,992
first reported quarter
Ownership
0.354%
of shares outstanding
% of Portfolio
0.48%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 97.9481943892125.ToString("F0")%
Shared 2.0003670799229134.ToString("F0")%
None 0.051438530864575185.ToString("F0")%
Derivatives in AZN
reported options exposure · as of Mar 31, 2026CallValue
$0
CallShares
0
PutValue
$1,972,200
PutShares
10,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $8,691,009,698 across 16 Drug Manufacturers - General names. AZN ranks #4 (12.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
6,786,107 | $1,658,795,994 | |
| 2 | LLY |
ELI LILLY & Co
|
1,563,625 | $1,438,175,365 | |
| 3 | ABBV |
AbbVie Inc.
|
5,571,610 | $1,211,769,456 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
5,491,992 | $1,083,130,660 | |
| 5 | MRK |
Merck & Co., Inc.
|
7,557,518 | $909,093,835 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
5,282,196 | $736,179,654 | |
| 7 | AMGN |
Amgen Inc
|
1,529,613 | $538,194,332 | |
| 8 | PFE |
Pfizer Inc
|
14,689,187 | $412,472,368 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,083,130,660 | 5,491,992 | Shares | Defined | 2026-05-15 | |
| 2026-03-31 | $1,972,200 | 10,000 | Put | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||